Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Wilson Therapeutics logo — Innovative pathways to treat rare conditions and enhance pat...

Wilson Therapeutics

Innovative pathways to treat rare conditions and enhance patient lives

Founded 2012 Post-IPO Equity Total: $284.00M Biotechnology, Health Care +1

General Information

Company Name Wilson Therapeutics
Founded Year 2012
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Wilson Therapeutics. To contact Wilson Therapeutics, visit wilsontherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Wilson Therapeutics compare?

A PDF of Wilson Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Wilson Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Wilson Therapeutics

Wilson Therapeutics is a Stockholm-based biopharmaceutical company founded in 2012. The company's slogan, "Innovative pathways to treat rare conditions and enhance patient lives," reflects its focus on creating advanced treatments for individuals with rare conditions such as Wilson Disease. Their premier product, Decuprate®, is currently undergoing evaluation in a Phase II clinical study for this indication. The company recently received a kr244.00M investment in Post-IPO Equity on 08 December 2017. With a strong emphasis on Biotechnology, Health Care, and Health and Wellness industries, Wilson Therapeutics is poised to make a significant impact in the field of rare disease treatment.

Business keywords: biopharmaceutical company, rare diseases, Wilson Disease, Stockholm, clinical study, patient treatments, Phase II, new therapies, Decuprate®, novel solutions, patient lives, innovative treatments

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity kr244.00M -
08 Dec 2017
Series B $40.00M 4
Abingworth HealthCap NeoMed Management
Abingworth, HealthCap +2
16 Apr 2014

Wilson Therapeutics Alternatives & Competitors

View All Alternatives
Wilson Therapeutics vs
Therachon
Therachon Switzerland

Life-Transforming Therapies - Developing novel therapeutics for serious rare conditions

Series B
1 employees
Biotechnology, Health and Wellness
Wilson Therapeutics vs
Larimar Therapeutics Inc.
Larimar Therapeutics Inc. United States

Clinical-stage biotechnology company focused on developing treatments for complex rare diseases.

Post-IPO Equity
84 employees
Biotechnology, Health and Wellness
Compare Wilson Therapeutics vs Larimar Therapeutics Inc.
Wilson Therapeutics vs
Affymax
Affymax

Pioneering innovative therapies for life-threatening conditions, aiming to enhance anemia treatment...

Venture round
51-200 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Wilson Therapeutics

Innovative pathways to treat rare conditions and enhance patient lives
Wilson Therapeutics was founded in 2012.
Wilson Therapeutics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on biopharmaceutical company, rare diseases, Wilson Disease and Stockholm.
Wilson Therapeutics has completed 2 funding rounds, raising a total of $284.00M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Wilson Therapeutics include Therachon, Larimar Therapeutics Inc., Affymax, Soligenix, Inc., Cirius Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Wilson Therapeutics and Therachon are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Wilson Therapeutics, https://bouncewatch.com/company/wilson-therapeutics, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout